Medicare Enrolled

Dr. Matthew Villerot, D.O.

Anesthesiology · Grand Rapids, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1900 WEALTHY ST SE STE 300, Grand Rapids, MI 49506
6167748345
In practice since 2015 (11 years)
NPI: 1386023224 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Villerot from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Villerot? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Villerot

Dr. Matthew Villerot is an anesthesiology specialist in Grand Rapids, MI, with 11 years of NPI registration. Based on federal Medicare data, Dr. Villerot performed 28,145 Medicare services across 943 unique beneficiaries.

Between the years covered by Open Payments, Dr. Villerot received a total of $12,644 from 9 pharmaceutical and/or device companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Villerot is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 0% volume in MI $12,644 industry payments

Medicare Practice Summary

Medicare Utilization ↗
28,145
Medicare services
Top 0% in MI for anesthesiology
943
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,559 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, ropivacaine hydrochloride, 1 mg 25,071 $0 $1
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
1,086 $1 $4
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
870 $0 $2
Midazolam injection, per 1 mg
Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments.
237 $0 $2
Contrast dye for imaging, lower concentration 124 $0 $8
Injection, fentanyl citrate, 0.1 mg 100 $1 $3
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
69 $224 $509
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
51 $196 $1,092
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
49 $421 $1,268
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
43 $178 $550
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
43 $184 $675
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint.
43 $204 $484
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
41 $189 $682
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
41 $100 $344
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
40 $162 $655
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
38 $98 $341
Facet joint nerve destruction, single joint
This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint.
33 $349 $1,083
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
29 $43 $257
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
29 $88 $222
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
27 $89 $300
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
25 $166 $563
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
24 $3 $10
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
18 $118 $347
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
14 $0 $9
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,644
Total received (2019-2024)
Avg $2,107/year across 6 years
Top 3% in MI for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
9
Companies
172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,644 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$839
2023
$1,910
2022
$2,653
2021
$2,204
2020
$2,421
2019
$2,616

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$314
Medtronic, Inc.
$232
Boston Scientific Corporation
$179
Stryker Corporation
$70
SPR Therapeutics, Inc
$45
Top 3 companies account for 86.3% of 2024 payments
All-time payments by company (2019-2024) ›
Nevro Corp.
$3,237
Abbott Laboratories
$2,697
Boston Scientific Corporation
$2,349
Relievant Medsystems, Inc.
$1,466
Medtronic, Inc.
$1,440
Medtronic USA, Inc.
$738
BOSTON SCIENTIFIC CORPORATION
$338
SPR Therapeutics, Inc
$204
Stryker Corporation
$174
Top 3 companies account for 65.5% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ETERNA · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Pain Management · INFINITY · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · MILD DEVICE KIT · Octrode SCS Leads · Omnia · PROCLAIM · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · SPECTRA WAVEWRITER · SPINEJACK · SPRINT PNS System · SUPERION · SYNCHROMED · SYNCHROMEDII · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · Superion · Superion Indirect Decompression System · VANTA ADAPTIVESTIM · Vanta · WaveWriter Alpha Prime 16
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for anesthesiology in MI.

Looking for an anesthesiology specialist in Grand Rapids?
Compare anesthesiologists in the Grand Rapids area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologists nearby

Geographic Context

Anesthesiologists within 10 mi
244
Per 100K population
37.0
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Villerot is a mixed practice specialist, with above-average Medicare volume (top 0% in MI), with low-engagement industry engagement in the top 3% of MI peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Villerot experienced with injection, ropivacaine hydrochloride, 1 mg?
Based on Medicare claims data, Dr. Villerot performed 25,071 injection, ropivacaine hydrochloride, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Villerot receive payments from pharmaceutical companies?
Yes. Dr. Villerot received a total of $12,644 from 9 companies across 172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Villerot's costs compare to other anesthesiologists in Grand Rapids?
Dr. Villerot's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Villerot) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →